Nasdaq

Nexalin Technology, Inc. Launches Clinical Trial for HALO™ Clarity Device to Treat Mild Traumatic Brain Injury and PTSD at UCSD

Nexalin Technology announces the shipment of HALO™ Clarity devices to UCSD for a clinical trial on mTBI and PTSD treatment. Nexalin Technology, Inc. has announced that the University of California, ...
GamesRadar+

Why now is the perfect time for a Halo: Combat Evolved remake

Halo is entering a new chapter. Now, for anyone who's stuck with the Halo games over a significant period of time over their 23-year history, those words could be a cause for concern, depending on ...
Nasdaq

Nexalin Technology, Inc. Receives IRB Approval for UCSD Clinical Trials of HALO™ Clarity Headset in Treating mTBI and PTSD

Nexalin Technology, Inc. has announced that it has received Institutional Review Board approval from the University of California, San Diego for clinical testing of its HALO™ Clarity headset, which ...
Seeking Alpha

Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA

HOUSTON, TX, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced plans to commence a new clinical trial in collaboration ...